Adaptation of WHO’s generic tuberculosis patient cost instrument for a longitudinal study in Africa
The WHO developed a generic ‘TB patient cost survey’ tool and a standardized approach to assess the direct and indirect costs of TB incurred by patients and their households, estimate the proportion of patients experiencing catastrophic costs, and measure the impact of interventions to reduce patien...
Main Authors: | Denise Evans, Craig van Rensburg, Caroline Govathson, Olena Ivanova, Friedrich Rieß, Andrew Siroka, Abdou K. Sillah, Nyanda Elias Ntinginya, Ilesh Jani, Farzana Sathar, Sydney Rosen, Ian Sanne, Andrea Rachow, Knut Lönnroth |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Global Health Action |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/16549716.2020.1865625 |
Similar Items
-
TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol
by: Andrea Rachow, et al.
Published: (2019-01-01) -
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
by: S. Koirala, et al.
Published: (2021-09-01) -
Catastrophic health expenditure among geriatric population of Lucknow district, India
by: Pavan Pandey, et al.
Published: (2017-01-01) -
Post-Tuberculosis (TB) Treatment: The Role of Surgery and Rehabilitation
by: Dina Visca, et al.
Published: (2020-04-01) -
Measuring Catastrophic Costs Due to Tuberculosis in Myanmar
by: Si Thu Aung, et al.
Published: (2021-07-01)